Q3: 2025-10-29 Earnings Abstract
EPS of -$0.61 beats by $0.44
| Income of $157.00M (17.16% Y/Y) beats by $26.49M
Ionis Prescription drugs, Inc. (IONS) Q3 2025 Earnings Name October 29, 2025 11:30 AM EDT
Firm Contributors
D. Walke – Senior Vice President of Investor Relations
Brett Monia – Founder, CEO & Director
Richard S. Geary – Govt VP & Chief Improvement Officer
Kyle Jenne – Govt VP & Chief World Product Technique Officer
Elizabeth L. Hougen – Govt VP of Finance & CFO
Convention Name Contributors
Jessica Fye – JPMorgan Chase & Co, Analysis Division
Huidong Wang – Barclays Financial institution PLC, Analysis Division
Michael Ulz – Morgan Stanley, Analysis Division
Yaron Werber – TD Cowen, Analysis Division
Gary Nachman – Raymond James & Associates, Inc., Analysis Division
Jason Gerberry – BofA Securities, Analysis Division
Yanan Zhu – Wells Fargo Securities, LLC, Analysis Division
Myles Minter – William Blair & Firm L.L.C., Analysis Division
Luca Issi – RBC Capital Markets, Analysis Division
Jay Olson – Oppenheimer & Co. Inc., Analysis Division
Mitchell Kapoor – H.C. Wainwright & Co, LLC, Analysis Division
Presentation
Operator
Good morning, and welcome to Ionis Third Quarter 2025 Monetary Outcomes Convention Name. As a reminder, this name is being recorded. Presently, I want to flip the convention over to Mr. Wade Walke, Senior Vice President of Investor Relations, to guide off the decision. Please start, sir.
D. Walke
Senior Vice President of Investor Relations
Thanks, Chuck. Earlier than we start, I encourage everybody to go to the Traders part of the Ionis web site to view the press launch and associated monetary tables we shall be discussing at the moment, together with a reconciliation of GAAP to non-GAAP financials. We consider non-GAAP monetary outcomes higher characterize the economics of our enterprise and the way we handle our enterprise. We’ve additionally posted slides on our web site that accompany at the moment’s name.
With me on the decision this morning are Brett Monia, our Chief Govt Officer; Richard Geary, our Chief Improvement Officer; Kyle Jenne, our Chief World Product
